PPC
BIIB icon

Park Place Capital’s Biogen BIIB Stock Holding History

Park Place Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.05K Buy
33
+22
+200% +$4.05K ﹤0.01% 659
2025
Q4 		$1.94K Hold
11
– – ﹤0.01% 723
2025
Q3 		$1.54K Hold
11
– – ﹤0.01% 730
2025
Q2 		$1.43K Hold
11
– – ﹤0.01% 754
2025
Q1 		$1.5K Buy
+11
New +$1.57K ﹤0.01% 756
2024
Q4 		– Sell
-7
Closed -$1.36K – 817
2024
Q3 		$1.36K Hold
7
– – ﹤0.01% 811
2024
Q2 		$1.62K Hold
7
– – ﹤0.01% 794
2024
Q1 		$1.51K Buy
+7
New +$1.64K ﹤0.01% 860
2023
Q4 		– Sell
-7
Closed -$1.8K – 880
2023
Q3 		$1.8K Sell
7
-2
-22% -$535 ﹤0.01% 935
2023
Q2 		$2.56K Sell
9
-12
-57% -$3.57K ﹤0.01% 926
2023
Q1 		$5.84K Buy
21
+14
+200% +$3.87K ﹤0.01% 847
2022
Q4 		$2K Buy
+7
New +$1.98K ﹤0.01% 937

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Park Place Capital's BIIB Position: Q1 2026 in Review

Park Place Capital increased its Biogen (BIIB) stake by 200% in Q1 2026, buying an estimated $4.05K and bringing the position to 33 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #659.

Park Place Capital first reported a position in BIIB in Q4 2022 and has held it in 12 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Park Place Capital held 33 shares of Biogen worth $6.05K as of Q1 2026.
  • Park Place Capital bought 22 Biogen shares in Q1 2026, an estimated $4.05K.
  • Biogen made up ﹤0.01% of Park Place Capital's portfolio in Q1 2026, its #659 holding.
  • Park Place Capital first reported a position in Biogen in Q4 2022 and has held it in 12 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.